Kyungbo Pharmaceutical rises 5.23% amid COVID-19 (Nafamostat) theme surge

On the 7th, the COVID-19 (Nafamostat) theme showed strength by rising 4.08% compared to the previous day, while Kyungbo Pharmaceutical, gaining attention as a related stock, surged 5.23% compared to the previous day. Kyungbo Pharmaceutical is known as a manufacturer and seller of pharmaceutical raw materials.

[Graph] Major stock price changes in the COVID-19 (Nafamostat) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Kyungbo Pharmaceutical ranked 5th out of 13 stocks in the quant financial ranking by exceeding the theme’s average scores in growth, stability, and profitability. This can be interpreted as Kyungbo Pharmaceutical having relatively high investment attractiveness compared to other stocks within the theme from a financial perspective.

[Table] Top stocks by financial scores within the theme

※ The quant financial scores are results analyzed by the Robo Algorithm based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.